CARLSBAD, Calif., Aug. 30,
2023 /PRNewswire/ -- Ionis Pharmaceuticals, Inc.
(Nasdaq: IONS) today announced that management will participate in
fireside chats at the following investor conferences:
- 2023 Wells Fargo Healthcare Conference on Wednesday, September 6, 2023
- Citi's 18th Annual BioPharma Conference on
Thursday, September 7, 2023
- Morgan Stanley 21st Annual Global Healthcare
Conference on Tuesday, September 12,
2023
A live webcast of these presentations can be accessed on the
Investors & Media section of the Ionis website at
https://ir.ionispharma.com/events-and-presentations/upcoming-events.
Replays will be available on the Ionis website within 48 hours and
will be archived for a limited time.
About Ionis Pharmaceuticals
For more than 30 years, Ionis has been a leader in RNA-targeted
therapy, pioneering new markets and changing standards of care.
Ionis currently has four marketed medicines and a promising
late-stage pipeline highlighted by cardiovascular and neurological
franchises. Our scientific innovation began and continues with the
knowledge that sick people depend on us, which fuels our vision to
become the leader in genetic medicine, utilizing a multi-platform
approach to discover, develop and deliver life-transforming
therapies.
To learn more about Ionis visit www.ionispharma.com and follow
us on Twitter @ionispharma.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/ionis-to-present-at-upcoming-investor-conferences-301912983.html
SOURCE Ionis Pharmaceuticals, Inc.